The New York Entrepreneur

Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness

Read Time:9 Second

Pfizer plans to share the findings at a scientific conference and publish them in a peer-reviewed scientific journal. The company will also submit the data to regulatory agencies for review.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Leveraged funds roll back bets against yen by widest margin in years as carry trade unwinds
Next post Venezuela restricts access to Binance and X amid election unrest